Furthermore, the authors confirmed that interleukin 6 receptor (IL6R) and proteasome subunit beta type 8 (PSMB8), which are targets of miR-451a, showed increased expression in patients with AD and a negative correlation with miR-451a concentration. Here, IL6R is linked to Alzheimer disease.